Presentation given by Louise Phillips at Transfusion Update, May 2011.

Slides:



Advertisements
Similar presentations
An audit of the antithrombotic therapy for the management of valve repair or replacement Gellatly RM 1,2, Maydelmin D 1, Connell C 1, Marasco S 3, Zimmet.
Advertisements

St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
HAIST HAIST The Hypothermia for Acute Ischaemic Stroke Trial Malcolm Macleod PhD FRCPE Senior Lecturer, Clinical Neurosciences, University of Edinburgh.
Public Research Funding in Health Emergencies – Australian Perspective and Strategies Clive Morris Head, Strategic Policy National Health and Medical Research.
An Essential Tool for Optimizing Clinical Outcomes and Improving Patient Safety: The Administrative and Clinical Standards for Patient Blood Management.
Total Hip Replacement and Musculoskeletal disorder research Tosan Okoro NWORTH Seminar May 2012.
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospice-based clinic to support the holistic needs of patients with advanced chronic.
Standard 7 – Blood and blood products
Single Unit Transfusion for Red Blood Cell Transfusion
Australasian Maternity Outcomes Surveillance System ‘AMOSS’ Working together to improve the Safety and Quality of Maternity Care in Australasia.
Statewide PCP Chairs and Executive Officers Tuesday 14 August 2012 Sylvia Barry Manager Partnerships and Primary Health.
May 2014 Paul Jones, MD MacTraumatic: Predicting Early Death in Trauma Patients.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Partnering for Healthcare- Associated Infection Prevention Andrea Alvarez, MPH HAI Program Coordinator Office of Epidemiology Virginia Department of Health.
NI Palliative Care Research Forum Setting the Scene: The milestones Dr S McIlfatrick University of Ulster/NHSCT.
Ten Years Longitudinal Follow-up Study of Sickle Cell Disease Patients Treated with Hydroxyurea in Four English Centres 2 nd July 2008 Annette Gilmore.
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Stroke Care. What has been achieved so far and what still needs doing? Tony Rudd.
THE JOINT COMMISSION PATIENT BLOOD MANAGEMENT PERFORMANCE MEASURES
An epidemic in transition: impacts of migration and local networks on HIV sequence diversity and infection transmission in Australia
No. 091 Bipolar Diathermy for Transurethral Resection of Prostate: 6 year Australian Single Regional Centre Experience Devang Desai (Urology Registrar),
A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.
Blood Conservation: Identifying Factors to Reduce Phlebotomy Induced Blood Loss in the PICU Stacey Valentine, MD MPH Instructor, Division of Critical Care.
Massive transfusion: New Protocol
DRAFT 11 Case Coordination Overview COMMUNITY AGENCIES- November 2011.
TXA in trauma patients: who should we treat and when?
Advances in Non-Invasive Monitoring
Transfusion Quiz “Their Lives in Your Hands” Doctors.
A tale of two patients Louise Phillips Presentation at TORC 2011 Annual Seminar Perioperative Patient Blood Management.
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
Towards a ANZ Hip Fracture Registry “Quality Care Costs Less”
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research.
The Health Roundtable NSW Safe Clinical Handover Program Presenter: James Dunne Agency for Clinical Innovation Innovation Poster Session HRT1215 – Innovation.
London cancer services: Implementing the model of care London Borough of Bromley Health Scrutiny Sub-Committee meeting Tuesday, November 15, 2011.
Knee Replacement Surgery Evaluating Rehabilitation Management Strategies Dr Marlene Fransen.
Andrew Thornton, Chairman, RAH HREC
Aims to evaluate different feeding policies for stroke patients: Are oral supplements effective? When should we start tube feeding? Is PEG better than.
AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update.
National Patient Safety Programme Clydebank 9 th November 2007.
Haemostasis Registry A Register to record all off-label use of recombinant activated Factor VII in Australia and New Zealand.
Monthly Journal article review: Vimmi Kang PGY 2
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
JOURNAL PRESENTATION By: Nur Izzatul Ashikin Harun Moderator: Dr Abdul Karim Othman.
© ANZDATA Registry TRANSPLANT WAITING LIST CHAPTER 7.
Andrew Thornton Chairman, HREC Royal Adelaide Hospital Low and Negligible Risk Research Update - Ethics.
Does Openness Improve Outcome ? The North-West Quality Improvement Program Dr R H Stables Cardiothoracic Centre Liverpool.
RBC transfusions in critically ill patients TMR Journal Club March 1, 2007 Maggie Constantine.
D. James Cooper Russell Gruen National Health & Medical Research Council (NHMRC) Funding dates:
Applying CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) in a Pre- Hospital Wilderness Context Paul B. Jones PGY1.
Sustaining Quality. “Expectations will always exceed capacity. The service must always be changing, growing and improving…”. Aneurin Bevan, 1948.
Proposals by Paramedical Staff to Initiate Rehabilitation in Patients with Critical Illness on Mechanical Ventilation Acknowledgements This study was approved.
WA Stroke Data Collection Data specifications/Definitions Andy Wu Senior Policy Officer Subacute Community & Aged Care Directorate.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Region 15 Regional Healthcare Partnership 13th Public Meeting
Keerti Singh, C Greaves, L Mohammed, A Kumar.
Complication Rates for Percutaneous Coronary Intervention in South Australia Aashray Gupta1, Rosanna Tavella1,2, Margaret Arstall1,3, Matthew Worthley1,2,
Consultant CPD, November 23rd 2016
Iv iron and your heart operation
Paul B S LAI Cluster Coordinator for Surgical Services (NTEC) &
AAHBC Convened in 1997 Originally titled the National Allied Health Benchmarking Consortium (NAHBC) Founded to facilitate the development of a standardised.
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Pathogen Reduction - Evaluation of Mirasol® in a Clinical Trial
Treatment of Thromboembolic Disease The Need for Multiple Perspectives
Monthly Journal article review: Vimmi Kang PGY 2
Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, Erica M
Professor Sabe Sabesan
Presentation transcript:

Presentation given by Louise Phillips at Transfusion Update, May 2011

Haemostasis Registry VTE Cohort Study A registry to collect information about the use of rFVIIa in Australia and New Zealand Department of Epidemiology and Preventive Medicine

transfusionoutcomes research collaborative Department of Epidemiology and Preventive Medicine

A partnership between Monash University and the Blood Service Aim: To improve understanding of blood product usage and the influence of transfusion practice on patient outcomes Established 2008 Department of Epidemiology and Preventive Medicine TTP Registry NAIT Registry Aplastic Anaemia Registry

TTP, NAIT, Aplastic Anaemia: Why Registries? Uncommon diseases even major centres encounter few cases associated with significant morbidity and mortality difficult to establish optimal management significant variation in practice disease rarity hampers definitive studies (eg clinical trials)

TTP, NAIT, Aplastic Anaemia: Why Registries? Registries collect common experience allow recognition of patterns in care and outcome are hypothesis generating provide baseline data and platform for further studies

Thrombotic Thrombocytopenic Purpura (TTP) Registry Estimate approx hospitals in Australia treating TTP 100 cases per year Steering Committee Shlomo Cohney (chair) Paul Cannell Claire Davies Sunelle Engelbrecht Danny Hsu Zoe McQuilten Stephen Opat Louise Phillips David Roxby Erica Wood

NZ *Auckland Progress 31 Hospitals participating 32 cases to date Plans to extend registry to include aHUS VIC ALF AUS Geelong MMC Northern RMH St Vincent’s *Western TAS LGH RHH ACT *TCH NSW Concord *Liverpool Nepean PWH RNS RPA St Vincent’s *Westmead Wollongong QLD *Gold Coast *PAH RBWH *Townsville SA FMC QEH *RAH WA Fremantle RPH *SCGH Thrombotic Thrombocytopenic Purpura (TTP) Registry *ethics or site governance in process

Neonatal Alloimmune Thrombocytopenia (NAIT) Registry Estimate approx 25 hospitals in Australia treating NAIT <50 cases per year Steering Committee Helen Savoia (chair) Stephen Cole Mark Davies Rhonda Holdsworth Zoe McQuilten Louise Phillips Shelly Rowland Ben Saxon Bronwyn Williams Erica Wood

VIC Mercy MMC RCH RWH TAS RHH ACT TCH NSW *CHW *John Hunter Nepean *RHW RNS RPA *Westmead Wollongong QLD Mater Mother’s RBWH *RCHQ SA FMC WCH WA KEMH RPH Progress 21 Hospitals participating 11 cases to date also collecting retrospective cases *ethics or site governance in process Neonatal Alloimmune Thrombocytopenia (NAIT) Registry

Aplastic Anaemia Registry few clinicians with a specific interest in aplastic anaemia but potentially treated at all major metropolitan hospitals including children’s and some private estimate approx 100 cases per year Current Status forming Steering Committee developing data dictionary talking to funders (Genzyme & Alexion) expect “go live” late 2011

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma

Early Coagulopathy of Trauma Project Lead: Dr Dev Mitra, PhD Student & Emergency Physician Markers of coagulopathy in trauma patients? – common tests and less-common tests When does coagulopathy establish? – coagulopathy testing at scene of trauma Can we recognise it when it begins? – possible use of point-of-care testing equipment Can we intervene in the pre-hospital phase? – potential trial of early treatment either on arrival at ED or in pre-hospital

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project

Australia’s blood supply in a major disaster or pandemic: How will we meet clinical demand? Department of Epidemiology and Preventive Medicine Transfusion Outcomes Research Collaborative Epidemiological Modelling Unit Infectious Diseases Unit

Pandemic project Limited data on recipients of blood products indication for transfusion urgency of requirement consequences of with-holding transfusion RBC, platelets and FFP No robust model of clinical demand impact of pandemic on clinical demand impact of pandemic or other disaster on supply how can demand be made to match supply? Planning for circumstances of shortage need a model to assist in developing or evaluating the impact of different triage approaches if blood supply limited

Modelling Demand for Blood Transfusions Transfusion Required Non-urgent (> 1 wk) Transfusion Required Semi-urgent (24 hrs - 1 wk) Transfusion Required Urgent ( hrs) Transfusion Required Acute (<1 hr) Not requiring transfusion Under “normal” circumstances:

Modelling Demand for Blood Transfusions Transfusion Required Non-urgent (> 1 wk) Transfusion Required Semi-urgent (24 hrs - 1 wk) Transfusion Required Urgent ( hrs) Transfusion Required Acute (<1 hr) Not requiring transfusion Death If no blood is available: 4 possible outcomes at each urgency level Outcomes more or less likely depending on disease Identified 14 disease groups Total of 56 disease/urgency combinations Estimate likelihood of the outcomes for each Use this information with volume of transfusion in each category to create model

Modelling Demand for Blood Transfusions Transfusion Required Non-urgent (> 1 wk) Transfusion Required Semi-urgent (24 hrs - 1 wk) Transfusion Required Urgent ( hrs) Transfusion Required Acute (<1 hr) Not requiring transfusion Death Once model is developed: able to project impact of different strategies of restriction eg with-hold transfusion from particular disease group or urgency level - how much is saved? model impact of pandemic on demand eg likely increase in demand from group (such as more ECMO) due to effect of pandemic

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry

MTR Demographic Information Clinical Coding ICD-10 AR-DRG Transfusion History Laboratory Results ?Pharmacy National or Local Databases/ Registries ANZICS ASCTS Trauma all patients receiving ≥5 units RBC in 4 hours any time in hospital admission any context of bleeding (trauma, surgical, obstetric, etc) all data collection electronic

MTR Demographic Information Clinical Coding ICD-10 AR-DRG Transfusion History Laboratory Results ?Pharmacy National or Local Databases/ Registries ANZICS ASCTS Trauma Progress recent scoping exercise identified 8 pilot hospital sites in four states negotiating details, ethics, costs involved expect “go live” September 2011 hope to expand to more hospitals in 2012

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO)

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) NHMRC Partnership Project Grant

Stream 3 Human Factors Stream 2 Modelling & Monitoring Stream 1 Registry Data TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) Stream 1: Registry Data Project Lead: Dr Zoe McQuilten, PhD Student & Clinical Fellow Clinical Registries exist and collect good quality data including risk adjustment and outcomes Data about transfusion is not included but is available from hospital laboratory information systems Stream 1 Registry Data

Stream 1: Registry Data Clinical Registries exist and collect good quality data including risk adjustment and outcomes Data about transfusion is not included but is available from hospital laboratory information systems Alfred Hospital Austin Hospital Geelong Hospital Monash Medical Centre Royal Melbourne Hospital St Vincent’s Hospital VSTORM (Trauma) ASCTS (Cardiac Surgery) ANZICS-APD (Intensive Care)

Stream 3 Human Factors Stream 1 Registry Data Stream 2 Modelling & Monitoring TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) Stream 1 Registry Data Stream 1: Registry Data Stream 2 Stream 2: Modelling & Monitoring Monitoring Modelling & Monitoring Statistical Control Chart (VLAD) methodology Transfusion Rate in Cardiac Surgery Transfusion above predicted rate Modelling following on from Pandemic Project projections of future clinical demand for transfusion ageing other changes in population demographics changes in transfusion dependency with new medications

Stream 1 Registry Data TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) Stream 3 Human Factors Stream 2: Modelling & Monitoring Stream 2 Modelling & Monitoring Stream 2 Monitoring Modelling & Stream 3 Human Factors Stream 3: Human Factors Project Lead: Dr Shelly Jeffcott Investigating aspects of clinical decision making in transfusion

Stream 1 Registry Data Stream 2 Modelling & Monitoring TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) Stream 3: Human Factors Stream 3 Human Factors Stream 3 Human Factors

TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry TRANSFUSION RESEARCH: IMPROVING OUTCOMES Stream 1 Registry Data Stream 2 Modelling & Monitoring Stream 3 Human Factors Stream 2 Modelling & Monitoring Stream 3 Human Factors Stream 1 Registry Data TRANSFUSION RESEARCH: IMPROVING OUTCOMES (TRIO) Obstetric Haemorrhage Study PROJECTS IN DEVELOPMENT

Obstetric Haemorrhage Study (in development) AMOSS surveillance system covers 94% births in Australasia Epidemiology of obstetric haemorrhage requiring blood transfusion Factors influencing variation in transfusion practice and outcomes Planned case control study of severe PPH

Obstetric Haemorrhage Study TTP Registry NAIT Registry Aplastic Anaemia Registry Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry TRANSFUSION RESEARCH: IMPROVING OUTCOMES Stream 1 Registry Data Stream 2 Modelling & Monitoring Stream 3 Human Factors Age of Blood (TRANSFUSE-RCT) (INFORM-RCT) PROJECTS IN DEVELOPMENT

INFORM-RCT (funding application submitted) pragmatic RCT in Canada and Australia (~10 sites in Aust) age of RBC: freshest available vs standard care all in-hospital transfusions randomised in Hospital Blood Bank all data collection electronic CIHR application submitted - requested $50 per patient mid-2011 to mid-2012

TRANSFUSE-RCT (funding application submitted) RCT in Australia & New Zealand ICUs (>50 sites) Age of RBC: freshest available vs standard care ICU patients, excluding cardiac surgery Randomised in ICU, flagged at Hospital Blood Bank Data collection in ICU NHMRC application submitted Mid

Obstetric Haemorrhage Study Age of Blood (TRANSFUSE-RCT) (INFORM-RCT) TTP Registry NAIT Registry Aplastic Anaemia Registry Department of Epidemiology and Preventive Medicine Early Coagulopathy of Trauma Pandemic Project Massive Transfusion Registry TRANSFUSION RESEARCH: IMPROVING OUTCOMES Stream 1 Registry Data Stream 2 Modelling & Monitoring Stream 3 Human Factors Wrong Blood in Tube

TORC Seminars November 2008 Transfusion Safety: Tackling the ‘Real’ Risks August 2009 Patient Consent in Blood Transfusion November 2010 Critical Bleeding and Massive Transfusion Perioperative Blood Management 9 September 2011 (watch this space )